Comment sont diagnostiquées les maladies complexes ?

Les maladies complexes sont diagnostiquées par des tests spécialisés, imageries et consultations multidisciplinaires.

Quels tests sont utilisés en soins tertiaires ?

Des tests avancés comme l'IRM, la biopsie et les tests génétiques sont couramment utilisés.

Quel rôle joue la génétique dans le diagnostic ?

La génétique aide à identifier des maladies héréditaires et à personnaliser les traitements.

Comment les consultations multidisciplinaires aident-elles ?

Elles permettent d'obtenir des avis d'experts de différentes spécialités pour un diagnostic précis.

Qu'est-ce qu'un diagnostic différentiel ?

C'est le processus d'élimination d'autres maladies ayant des symptômes similaires.

Quels symptômes nécessitent un soin tertiaire ?

Des symptômes graves ou persistants comme des douleurs intenses, des troubles neurologiques.

Comment reconnaître une urgence médicale ?

Des signes comme la difficulté à respirer, la perte de conscience ou des douleurs thoraciques.

Les symptômes varient-ils selon les spécialités ?

Oui, chaque spécialité peut présenter des symptômes spécifiques selon les pathologies traitées.

Quels symptômes sont liés aux maladies rares ?

Des symptômes atypiques ou non spécifiques, souvent mal compris ou mal diagnostiqués.

Comment les symptômes évoluent-ils dans le temps ?

Ils peuvent s'aggraver, se stabiliser ou s'améliorer selon le traitement et la maladie.

Comment prévenir les maladies complexes ?

La prévention passe par des dépistages réguliers, un mode de vie sain et des vaccinations.

Quel rôle joue l'éducation à la santé ?

L'éducation à la santé informe les patients sur les risques et les comportements à adopter.

Les vaccinations sont-elles importantes ?

Oui, elles protègent contre certaines maladies graves et réduisent les complications.

Comment le dépistage précoce aide-t-il ?

Il permet de détecter les maladies à un stade précoce, augmentant les chances de traitement efficace.

Quels conseils de mode de vie peuvent aider ?

Adopter une alimentation équilibrée, faire de l'exercice et éviter le tabac et l'alcool.

Quels traitements sont offerts en soins tertiaires ?

Des traitements avancés comme la chirurgie spécialisée, la chimiothérapie et la radiothérapie.

Comment les traitements sont-ils personnalisés ?

Ils sont adaptés selon le profil génétique et les caractéristiques spécifiques du patient.

Quel est le rôle des essais cliniques ?

Les essais cliniques testent de nouveaux traitements et améliorent les options disponibles.

Comment la réhabilitation est-elle intégrée ?

La réhabilitation est essentielle pour aider les patients à retrouver leur autonomie après un traitement.

Quels traitements sont utilisés pour les maladies chroniques ?

Des traitements à long terme comme les médicaments, la thérapie physique et le suivi régulier.

Quelles sont les complications possibles des traitements ?

Les complications peuvent inclure des infections, des effets secondaires et des rechutes.

Comment gérer les complications ?

La gestion implique un suivi régulier, des ajustements de traitement et un soutien psychologique.

Les complications sont-elles prévisibles ?

Certaines complications peuvent être anticipées, d'autres surviennent de manière imprévisible.

Quel impact les complications ont-elles sur le patient ?

Elles peuvent affecter la qualité de vie, nécessiter des soins supplémentaires et prolonger la maladie.

Comment les complications influencent-elles le traitement ?

Elles peuvent nécessiter des modifications du traitement initial pour éviter des risques supplémentaires.

Quels sont les facteurs de risque des maladies complexes ?

Les facteurs incluent l'hérédité, l'âge, le mode de vie et certaines conditions médicales.

Comment l'environnement influence-t-il la santé ?

L'exposition à des toxines, la pollution et le stress peuvent augmenter le risque de maladies.

Le mode de vie affecte-t-il les risques ?

Oui, des habitudes comme le tabagisme, l'inactivité physique et une mauvaise alimentation augmentent les risques.

Les antécédents familiaux sont-ils importants ?

Oui, des antécédents familiaux de maladies peuvent indiquer un risque accru pour les individus.

Comment le stress impacte-t-il la santé ?

Le stress chronique peut affaiblir le système immunitaire et augmenter le risque de maladies.

Centres de soins tertiaires - Informations médicales vérifiées

Risk of Recall for Total Joint Arthroplasty Devices Over 10 Years.

08 2023

DOI: 10.1016/j.arth.2023.01.068 PMID: 36773660

Orthopaedic devices comprise nearly 20% of devices on the market and 12% to 20% of these devices undergo a recall within 10 years. More than 95% of these devices are approved without supporting clinic... The FDA 510(k) database was queried for orthopaedic devices approved between January 01, 2008 and December 31, 2018 and subsequently codified to hip and knee arthroplasty devices using product codes. ... In total, 94 (19.4%) hip and 85 (20.3%) knee devices were recalled. The hazard of recall by 10 years for hip and knee arthroplasty devices was approximately 24%, with no statistical differences betwee... The risk of recall for arthroplasty devices is more than that previously understood. Improved postmarket surveillance strategies along with increased physician participation in detecting and reporting...

United States Humans Medical Device Recalls United States Food and Drug Administration Product Surveillance, Postmarketing +3 autres

Software-related recalls in computer-assisted hip and knee arthroplasty.

03 2023

DOI: 10.1007/s00264-023-05692-2 PMID: 36637462

Computer-assisted arthroplasty supports the surgeons in planning, simulating, and performing the replacement procedure, using robotic or navigation technologies. However, the safety of the technology ... The Medical Device Recalls database was investigated about software-related recalls in computer-assisted hip and knee arthroplasty surgery, between 2017 and 2022. The incidence of the software-related... Eighteen recall numbers could be identified (1.6%), corresponding to 11 recall events. A total of 4634 units were involved. The FDA determined root causes were: software design (66.6%), design change ... Software-related recalls in computer-assisted hip and knee arthroplasty were quite uncommon among all the recalls, deemed non-life threatening and usually due to software design errors. The main actio...

Humans Arthroplasty, Replacement, Knee Robotics Software Medical Device Recalls +2 autres

Investigation and analysis of four countries' recalls of osteosynthesis implants and joint replacement implants from 2011 to 2021.

07 Oct 2022

DOI: 10.1186/s13018-022-03332-w PMID: 36207755

Medical devices are used in almost all orthopedic surgical subspecialties, and the frequency of adverse events is increasing, which should not be ignored. To provide suggestions on how to avoid implan... The research extracted recalls of osteosynthesis implants and joint replacement implants from January 1, 2011, to June 30, 2021, in the CNMPA, FDA, HC and ATGA websites and collected the information o... A total of 315 cases of osteosynthesis implants and 286 cases of joint replacement implants were reported in China, the USA, Canada and Australia. The recalls number from 2016 to 2021 was more than th... To avoid the recalls of such implants, manufacturers should strictly select implant materials and components, develop detailed labels and instructions, severely control the packaging process and estab...

Arthroplasty, Replacement Australia Humans Medical Device Recalls Prostheses and Implants +1 autres

Communicating medical device recalls: A rapid review of the literature.

06 Mar 2024

DOI: 10.1016/j.pec.2024.108244 PMID: 38484598

The U.S. Food and Drug Administration (FDA) currently regulates more than 190,000 different medical devices. Like all products, these devices may be subject to manufacturing problems, flawed designs, ... To support this recommendation, we conducted a rapid review of literature published from 2008-2022 to capture and examine information on risk communication approaches, methods, and best practices for ... We identified 23 articles to include in our review.... Our review found a lack of research-based studies as well as gaps in understanding about consumer perspectives, comprehension, and communication preferences related to recalls. Despite these limitatio... Further research is needed to assess consumer attitudes, understanding, and preferences and to reach consensus on best practices for effectively communicating recall information to consumers of medica...

A Comprehensive Analysis of Class I Medical Device Recalls: Unveiling Patterns, Causes and Global Impacts.

Aug 2024

DOI: 10.7759/cureus.67542 PMID: 39310387

In the landscape of medical device regulation, Class I recalls serve as pivotal indicators of potential risks, necessitating comprehensive analysis to unveil underlying patterns and causal factors. Th...

Ten-year Risk of Recall of Novel Spine Devices.

26 Jan 2024

DOI: 10.1097/BRS.0000000000004939 PMID: 38273730

Observational epidemiological study.... This study's primary objective was to examine the risk of recall for novel spine devices over time. Secondarily, we sought to analyze interbody fusion and vertebral body replacement (VBR) devices (cor... The recall risk of a novel spine device over time has not been reported. Additionally, FDA regulations were lowered for interbody fusion devices to enter the market in 2007. As well, VBR implants were... Spine devices cleared between January 1, 2008 and December 31, 2018 were identified from the FDA's 510(k) database. All recall data was collected from the database in January of 2021 to provide a 2-ye... 2,384 spine devices were cleared via 510(k) in the study period. The hazard of recall at 5 years was 5.3% (95% CI: 4.4%-6.2%) and 6.5% (95% CI: 5.4-7.7%) at 10 years. No significant difference in reca... The risk of recall at 5 and 10 years of a novel spine device is about half the 12% rate reported for orthopedic devices in general. Despite lowered FDA regulations for interbody fusion devices and rec... V....

Risk of Recall Associated With Modifications to High-risk Medical Devices Approved Through US Food and Drug Administration Supplements.

03 04 2023

DOI: 10.1001/jamanetworkopen.2023.7699 PMID: 37043202

High-risk medical devices approved by the US Food and Drug Administration (FDA) can undergo modifications to their original premarket approval (PMA) via 1 of 5 types of supplements. Only panel track s... To determine the association between PMA supplements and the risk of any device recall and high-risk (class 1) recall.... In this cohort study, the FDA database was queried for original devices approved via PMA from January 1, 2008, through December 31, 2019. Supplement and recall data were obtained for these devices fro... Supplements submitted by manufacturers for FDA approval to modify devices.... A mixed-effects Cox proportional hazards regression model with frailty terms was used, modeling device recall as an outcome variable during the observation period. A second model was performed for cla... A total of 373 original PMA devices with 10 776 associated supplements were included in the analysis. A median 2.5 (IQR, 1.2-5.0) supplements per device were approved annually. Cardiovascular devices ... The findings of this cohort study suggest that PMA supplements are associated with an approximately 30% increased risk of any recall and class 1 recall. The FDA processes for approving modifications t...

United States Humans United States Food and Drug Administration Retrospective Studies Cohort Studies +2 autres

A Comparison of Patient and Device Issues Reported for Recalled Venous Stent Systems.

Nov 2022

DOI: 10.1016/j.avsg.2022.08.002 PMID: 36055459

The first two Food and Drug Administration (FDA)-approved stents for treatment of iliofemoral vein obstruction, Boston Scientific's Vici and BD's Venovo venous stent systems, were both recalled in ear... MAUDE was queried for all adverse event reports for brands "Vici" and "Venovo" from their respective US FDA market approval dates to August 19, 2021. Reported device issues, patient issues, and interv... A total of 50 unique adverse event reports were compiled for the Vici system and 341 for the Venovo system. The most common device issue reported for the Vici system was migration (48% vs. 0%; P = 0.0... While 2 venous stent systems were recalled simultaneously, significant differences exist between reported device issues in MAUDE and whether patient injury was involved and well described. Our data su...

United States Humans Treatment Outcome Stents United States Food and Drug Administration +2 autres

Characterization of US Food and Drug Administration Class I Recalls from 2018 to 2022 for Moderate- and High-Risk Medical Devices: A Cross-Sectional Study.

2023

DOI: 10.2147/MDER.S412802 PMID: 37229515

Medical device recalls are initiated in response to safety concerns. Class I (highest severity) recalls imply a reasonable likelihood of serious adverse events or death associated with device use. Rec... To characterize Class I medical device recalls and corresponding recalled devices.... This was a cross-sectional study of Class I recalls posted on the Food and Drug Administration's annual log from January 1, 2018 to June 30, 2022 for moderate-risk and high-risk medical devices. Devic... There were 189 unique Class I medical device recalls, including 151 (79.9%) for moderate-risk and 34 (18.0%) for high-risk devices. Sixty-five (34.4%) recalls were for cardiovascular devices, 36 (19.0... High-severity medical device recalls are common and affect millions of device units annually in the US. Recall termination takes a significant amount of time, putting patients at risk for serious safe...

Emotion Recognition from Physiological Signals Collected with a Wrist Device and Emotional Recall.

11 Nov 2023

DOI: 10.3390/bioengineering10111308 PMID: 38002432

Implementing affective engineering in real-life applications requires the ability to effectively recognize emotions using physiological measurements. Despite being a widely researched topic, there see...

Centres de soins tertiaires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Questions fréquentes et termes MeSH associés

Diagnostic 5

Symptômes 5

Prévention 5

Traitements 5

Complications 5

Facteurs de risque 5

Contenu validé par Dr Olivier Menir

Auteurs principaux

Sources (10000 au total)